Antibodies having a mutated amino acid residue at position 268 (CH2 region) in constant regions
Details for Australian Patent Application No. 2004283135 (hide)
International Classifications
Event Publications
4 May 2006 PCT application entered the National Phase
PCT publication WO2005/040217 Priority application(s): WO2005/040217
14 August 2008 Application Accepted
Published as AU-B-2004283135
11 December 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004283137-4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
2004283133-Mirror glass component comprising an integrated luminous film
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser